PCV34 THE COST-EFFECTIVENESS OF ALISKIREN AS ADD ON TO...

PCV34 THE COST-EFFECTIVENESS OF ALISKIREN AS ADD ON TO LOSARTAN AND OPTIMAL ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH TYPE 2 DIABETES, HYPERTENSION AND NEPHROPATHY IN THE UNITED KINGDOM SETTING

JL Palmer, VC Munk, R Kotchie, G Vincze, Charney k, D Tucker, L Annemans
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
11
Year:
2008
Language:
english
DOI:
10.1016/s1098-3015(10)70622-7
File:
PDF, 75 KB
english, 2008
Conversion to is in progress
Conversion to is failed